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Abstract
Background: Hyphal growth and multidrug resistance of C. albicans are important features for virulence and antifungal
therapy of this pathogenic fungus.
Methodology/Principal Findings: Here we show by phenotypic complementation analysis that the C. albicans gene AGE3 is
the functional ortholog of the yeast ARF-GAP-encoding gene GCS1. The finding that the gene is required for efficient
endocytosis points to an important functional role of Age3p in endosomal compartments. Most C. albicans age3D mutant
cells which grew as cell clusters under yeast growth conditions showed defects in filamentation under different hyphal
growth conditions and were almost completely disabled for invasive filamentous growth. Under hyphal growth conditions
only a fraction of age3D cells shows a wild-type-like polarization pattern of the actin cytoskeleton and lipid rafts. Moreover,
age3D cells were highly susceptible to several unrelated toxic compounds including antifungal azole drugs. Irrespective of
the AGE3 genotype, C-terminal fusions of GFP to the drug efflux pumps Cdr1p and Mdr1p were predominantly localized in
the plasma membrane. Moreover, the plasma membranes of wild-type and age3D mutant cells contained similar amounts
of Cdr1p, Cdr2p and Mdr1p.
Conclusions/Significance: The results indicate that the defect in sustaining filament elongation is probably caused by the
failure of age3D cells to polarize the actin cytoskeleton and possibly of inefficient endocytosis. The high susceptibility of
age3D cells to azoles is not caused by inefficient transport of efflux pumps to the cell membrane. A possible role of a
vacuolar defect of age3D cells in drug susceptibility is proposed and discussed. In conclusion, our study shows that the ARF-
GAP Age3p is required for hyphal growth which is an important virulence factor of C. albicans and essential for
detoxification of azole drugs which are routinely used for antifungal therapy. Thus, it represents a promising antifungal drug
target.
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Introduction
Candida albicans is one of the most prevalent human fungal
pathogens. Depending on environmental conditions it is able to
grow in several distinct cell forms, such as yeast cells, different
pseudohyphal forms and true hyphae [1,2]. Apart from other
properties of C. albicans [3] hyphal development strongly
contributes to its success as a pathogen [4].
Hyphal growth of C. albicans can be induced in vitro by varying
growth conditions [5] and is controlled by a complex network of
transcriptional activators and repressors [6,7]. Recently, the group
of David Kadosh and we independently identified a new central
activator of hyphal development, UME6, that is required under all
conditions of hyphal induction [8,9]. Hyphae formation starts
from a yeast-form cell (blastospore) by forming a germ tube which
elongates until the first cell division. Before branching of the
filament, further cell divisions in the growing filament take place
only in the apical cell. Germ tube formation and hyphal
elongation are the result of polarized growth [10]. The latter
depends on the polarization of the actin cytoskeleton [11–14].
Several other hyphae-specific structures or properties depend on
the polarized actin cytoskeleton. Among these, at the hyphal tip
the Spitzenko¨rper (tip body), a hyphae-specific organelle closely
beneath the polarisome, is present [15] and lipid rafts (sterol- and
sphingolipid-enriched membrane domains) are highly concentrat-
ed at the tip [16].
Mucosal and systemic infections caused by C. albicans and other
Candida species are treated by drugs belonging to several different
chemical classes, e.g. azoles, polyenes and echinocandins [17].
However, antifungal therapy is often not successful and has
become a serious problem due to the emergence of multidrug-
resistant strains that result from extended use of antifungal drugs
over the last decades [18]. Many Candida species including
C. albicans have a high natural tolerance for antifungal drugs.
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Several highly potent drug efflux pumps that reside in the
cytoplasmic membrane have different but overlapping substrate
spectra to transport toxic compounds out of the cell [19]. There
are two families of drug transporters. The ABC (ATP-binding
cassette)-transporter family, which includes Cdr1p and Cdr2p,
use the energy of ATP hydrolysis to extrude their substrates. The
MFS (major facilitator superfamily) proteins (e.g. Mdr1p) use a
drug/proton antiport system. Among other mechanisms, multi-
drug resistance of clinical Candida strains is often caused by higher
expression of genes encoding drug efflux pumps [19–21]. Taken
together, there is a high demand for the development of
new antifungal drugs and the identification of potential drug
targets.
The Saccharomyces cerevisiae gene GCS1 [22,23] encodes an ARF-
GAP (ADP-ribosylation factor (ARF) GTPase-activating protein
(GAP)) [24]. Several recent reviews discuss the various functions
and properties of ARF proteins and ARF-GAPs in detail [25–27].
The GTP-bound form of ARF proteins is required for vesicle coat
formation. Uncoating and formation of the naked transport
vesicle is triggered by the GTPase activity of ARFs, which strictly
depends on activation by ARF-GAPs. Gcs1p activates the
intrinsic activity of Arf1p, Arf2p [24] and Arl1p (ARF-like
protein 1) [28]. In S. cerevisiae for the products of four genes an
ARF-GAP activity has been demonstrated [29]: GCS1, GLO3,
AGE1 and AGE2. The functions of these proteins in distinct
intracellular vesicle routes partially overlap. The C. albicans
genome carries homologs for each of these genes. GCS1 appears
to be the most important ARF-GAP in yeast because it shows
synthetic lethality with other ARF-GAPs [29], is involved in
several routes of intracellular vesicle traffic and has functions
in both exocytosis and endocytosis [28,30–32]. Colocalization
studies revealed that Gcs1p is predominantly present in Golgi and
endosomal compartments [33].
Apart from its ARF-GAP activity Gcs1p is also required for
other processes in vesicle traffic, such as vesicle coat formation and
vesicle docking with the target membrane by interaction with v-
SNAREs [33,34]. Furthermore, Gcs1p is required for mainte-
nance of mitochondrial morphology [35], for formation of the
prospore membrane in sporulation [36] and, like ARF-GAPs of
other organisms, for the proper actin cytoskeletal organization by
stimulating actin polymerization [27,37].
In a systematic phenotypic study of C. albicans homologs of genes
essentially required for ascospore formation in S. cerevisiae, we
deleted the C. albicans homolog (orf19.3683) of ScGCS1. In
consensus with Epp et al. [38], who have shown very recently
that cells lacking this ORF are nearly avirulent in the murine
model of disseminated infection and are killed by azole drugs
instead of being growth inhibited, we call this C. albicans
homolog ‘‘AGE3’’, because the gene name ‘‘GCS1’’ has been used
already for the C. albicans ortholog of the S. cerevisiae gene GSH1
[39].
Here we show that AGE3 complements several defects of the S.
cerevisiae gcs1D strain. Thus, AGE3 is indeed the functional ortholog
of yeast GCS1. A clear delay of endocytosis in age3D cells is also
shown. Mutant age3D cells have a severe defect in filament
formation under several different hyphal growth conditions. We
found that this is probably caused by defects in polarization of the
actin cytoskeleton and lipid rafts of age3D cells. We also show that
age3D cells are highly susceptible to several unrelated toxic
compounds including azoles which are in use in antifungal
therapy. Results of three experiments strongly indicate that the
drug susceptibility of age3D cells is not the consequence of
inefficient transport to the cell membrane or low activity of the
drug efflux pumps Cdr1p, Cdr2p and Mdr1p.
Materials and Methods
Strains, media and growth conditions
The strains used in this study are listed in Table 1. For growing
S. cerevisiae and C. albicans strains in the yeast-form, the cells were
cultured at 30uC either in YPD (1% yeast extract, 2%
bactopeptone and 2% dextrose) or in SD medium (0.17% yeast
nitrogen base, 0.5% ammonium sulfate, 2% dextrose) supple-
mented with the appropriate amino acids for auxotrophic strains.
For sporulation of diploid S. cerevisiae strains, cells were removed
from YPD agar after fresh growth in patches of 161 cm for
Table 1. C. albicans and S. cerevisiae strains used in this study.
Strain Parent Relevant genotype (otherwise see parent genotype) Source
C. albicans strains
SC5314 Wild-type clinical isolate [80]
SN87 SC5314 leu2D/leu2D his1D/his1D URA3/ura3D IRO1/iro1D [47]
UZ22 SN87 age3D::CmLEU2/AGE3 his1D/his1D This study
UZ45 UZ22 age3D::CdHIS1/age3D::CmLEU2 This study
UZ55 UZ45 age3D/age3D::AGE3 (PACT1-CaSAT1)* This study
TL19 SC5314 AGE3/AGE3 CDR1/CDR1 RPS1/rps1::Ptet-CDR1-GFP (PACT1-HygB
R)* This study
TL20 UZ45 age3D/age3D CDR1/CDR1 RPS1/rps1::Ptet-CDR1-GFP (PACT1-HygB
R)* This study
TL21 SC5314 AGE3/AGE3 MDR1/MDR1-GFP (Ptet-MDR1 PACT1-HygB
R)* This study
TL22 UZ45 age3D/age3D MDR1/MDR1-GFP (Ptet-MDR1 PACT1-HygB
R)* This study
S. cerevisiae strains
BY4743 S288C Mat a/a his3D1/his3D1 leu2D0/leu2D0 [57]
ydl226c+/2 BY4743 gcs1D::kanMX4/GCS1 [81]
ydl226c2/2 BY4743 gcs1D::kanMX4/gcs1D::kanMX4 [78]
UZ177 ydl226c2/2 gcs1D::kanMX4/gcs1D::kanMX4 (centromeric plasmid pCaAge3-2: URA3 PTet-CaAGE3) This study
*Gene fusions in parentheses denote integration of a complete plasmid carrying these fusions into the locus indicated.
doi:10.1371/journal.pone.0011993.t001
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16 hours at 30uC, resuspended in 1% potasium acetate at a
concentration of 16108 cells per ml and 100 ml of the suspension
were spotted onto 1% pottasium acetate agar containing 50 mg/ml
doxycycline (and for control, without doxycycline). After five days
of spore formation at 28uC, the cells were removed from the
plates, resuspended and the sporulation efficiency determined after
microscopic quantification.
For filamentous growth of C. albicans in liquid media the cells
were incubated at 37uC in either of the following media: YPD
+10% bovine serum with or without buffering with 20 mM
potassium phosphate to pH 7.5, 2.5 mM N-acetylglucosamine
(GlcNAc) in 0.335% yeast nitrogen base with ammonium sulfate,
RPMI-1640 (GIBCO-BRL) or Spider medium [40]. Agar plates
(2% agar) for filamentous growth were prepared using Spider
medium. For filamentous growth under embedded conditions at
37uC YPS agar (1% yeast extract, 2% bactopeptone, 2% sucrose,
1% agar) was prepared and the cells embedded as described [41].
Plasmid constructions
Oligonucleotide primers used for PCR amplification and all
plasmids used and constructed are listed in Tables S1 and S2,
respectively.
Construction of pCaAge3-Sat2 used for reintegration of the
AGE3 gene into the homozygous age3D strain was done as follows.
First, a gene cassette which is composed of the SAT1 gene
(conferring nourseothricin resistance) located between the ACT1
promoter and the ADH1 terminator sequence was PCR-amplified
from plasmid pSDS4 (Bito A., unpublished). The latter carries
modified fragments from pSFS1A [42] and the cassette was
amplified using the oligonucleotides CaAct1-Spe-Nar und
CaAdh1-Aat followed by digestion with NarI and AatII. This
cassette was cloned into YCplac33 [43], resulting in plasmid
pCaAct-Sat1. The AGE3 gene including 100 bp upstream of the
ORF was PCR-amplified with oligonucleotides CaAge3-9 and
CA0423-2. The PCR product was digested with SalI and SmaI and
inserted into pCaAct-Sat1 resulting in plasmid pCaAge3-Sat2.
The nucleotide sequence of the AGE3 gene was verified.
The plasmid pCaAge3-2 used for complementation of the yeast
gcs1D strain by CaAGE3 was constructed by amplification of the
AGE3 ORF from C. albicans genomic DNA using the primers
CaAge3-7 and CaAge3-8, digestion of the PCR product by BamHI
and insertion into plasmid pCM252-U. The latter was derived
from pCM252 [44] by replacement of the resident ScTRP1 gene
(ScaI fragment) by ScURA3 which had been isolated from
YCplac33 [43] by partial digestion with ScaI.
Plasmid pTet-GFP which carries a C. albicans codon-optimized
hygromycin B resistance gene (Wong et al., poster 89B presented at
the 7th ASM conference on Candida and Candidiasis, Austin,
Texas, USA) was the starting plasmid for generating C-terminal
GFP fusions. It was constructed in five steps and included
fragments of pAU22 [45] and CIp10 [46]. A detailed description
of the cloning steps and the plasmid maps are shown in Fig. S2.
The plasmids pCdr1-GFP and pMdr1-GFP encoding the
respective fusion proteins were constructed by insertion of PCR
products amplified by the primer pairs CaCdr1-Sal/CaCdr1-Ngo
and CaMdr1-Eco/CaMdr1-Ngo, respectively. The PCR products
and the vector were digested with NgoMIV and EcoRI (MDR1
ORF) or NgoMIV and SalI (CDR1 ORF) and ligated.
C. albicans strain constructions
The strains used are listed in Table 1.
The heterozygous and homozygous age3 deletion strains, UZ22
and UZ45, were constructed as described by Noble and Johnson
[47]. To this end, the regions (about 300 bp) immediately
upstream and downstream of the AGE3 open reading frame, and
the marker gene cassettes CdHIS1 and CmLEU2 were amplified
either from the Candida genome or from the plasmids pSN52 and
pSN40 [47], respectively. The PCR primers used were CaAge3-
d1 and CaAge3-d3, CaAge3-d4 and CaAge3-d6, and CaUniv-2
and CaUniv-5 for the region immediately upstream and
downstream of the AGE3 ORF and the auxotrophic marker
genes, respectively (Table S1). The gene deletion cassette was
generated by fusion PCR and integrated into the genome of
strain SN87 [47]. The AGE3-reconstituted strain UZ55 was
generated by integration of plasmid pCaAge3-Sat2 (Table S2),
which had been linearized before by Bsp1407I digestion, at the
native AGE3 promoter of the age3D strain, thereby reconstituting
one wild-type AGE3 gene copy. After transformation, recombi-
nant clones were selected on YPD agar containing 200 mg/L
nourseothricin. For both the homozygous age3 deletion strains
and the reconstituted strains the expected structural genomic
alterations were confirmed by both PCR (not shown) and
Southern blots (Fig. S1).
To construct strains that encode C-terminal fusions of GFP [48]
to Cdr1p and Mdr1p, respectively, the plasmid pCdr1-GFP was
linearized with the restriction enzyme AgeI and inserted into one
allele of the C. albicans RPS1 gene, whereas pMdr1-GFP was
linearized with KpnI and inserted into the MDR1 ORF. After
transformation of the wild-type strain SC5314 and the age3D strain
with pCdr1-GFP or pMdr1-GFP, the transformants were selected
on agar plates containing 200 mg/ml (for the age3D strain) or
1000 mg/ml hygromycin B (wild-type strain). Plasmid integration
at the expected loci was confirmed by PCR. As the consequence of
the different integration sites the expression of the CDR1-GFP
cassette is controlled by the Tet promoter [49] whereas theMDR1-
GFP cassette is controlled by the MDR1 promoter. Thus, chimeric
gene expression of cells was induced by addition of 50 mg/ml
doxycycline (Cdr1p-GFP) or 25 mg/ml benomyl (Mdr1p-GFP) for
four hours.
RNA isolation, Northern blotting and quantitative reverse
transcriptase PCR (qRT-PCR)
Total RNA was isolated from cells grown to logarithmic phase
in YPD or induced for filamentous growth in YPD+serum by
using the RNeasyH Mini Kit from Qiagen. Northern blot analysis
was done as described elsewhere [9]. For synthesis of the AGE3-
specific probe, a PCR product was amplified by using the
oligonucleotide primers CaAge3-4 and CaAge3-5 (Table S1). The
antisense strand was labelled by incorporation of [a-32P]-dATP in
a single-stranded PCR reaction. After hybridization, transcripts
were made visible by phosphoimaging (Fujifilm BAS-1800 II
phosphoimager). As a control for RNA quantity and transfer
efficiency rRNA was stained on the blot with methylene blue.
Quantitative AGE3 gene expression was determined by qRT-
PCR analysis. After degrading residual DNA from the RNA
samples by DNaseI cDNA synthesis was performed using the
GoScriptTM Reverse Transcription System (Promega Corp.).
Gene-specific fragments of ACT1 (control for constitutive
expression) and AGE3 were amplified by real-time PCR (primer
pairs CaAct1-10/CaAct1-11 and CaAge3-9A/CaAge3-10, re-
spectively) in a Corbett Rotor-Gene RG-3000 machine using the
GoTaqH qPCR Master Mix (Promega Corp.). The relative
AGE3 expression levels of different strains were calculated by the
DDCt method (normalization to ACT1 expression). For each
cDNA sample real-time PCR was done in duplicate and
the experiments were repeated once on a different day for
reproducibility.
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Plasma membrane isolation and Western blotting
The plasma membranes of Candida yeast cells grown in YPD to
exponential phase (OD600 = 1.0) were purified as described by
Panaretou and Piper [50]. For induction of CDR1 and CDR2
expression 10 mg/ml b-estradiol [51], and for MDR1 induction
25 mg/ml benomyl had been added to the medium for one hour
before harvesting the cells. After separation of membrane proteins
(10 mg) by SDS-PAGE (10% polyacrylamide gels) and blotting
onto nitrocellulose membranes, the blots were incubated with
polyclonal antibodies raised against Cdr1p, Cdr2p or Mdr1p
(kindly provided by D. Sanglard) [52]. After incubation with
secondary antibodies (goat anti rabbit) conjugated with alkaline
phosphatase (AP) the drug transporters were visualized by staining
the blots with the AP substrate 5-bromo-4-chloro-3-indolyl
phosphate (BCIP) and nitro blue tetrazolium (NBT).
Staining procedures, fluorescence microscopy and
rhodamine 6G influx/efflux
Endocytosis under yeast growth conditions was investigated by
staining of endocytotic vesicles with FM4-64 [53] as follows. Cells
were grown in YPD to an OD600 of 0.5, harvested by centrifugation
and resuspended in 300 ml YPD containing 2.5 ml FM4-64 stock
solution (stock 1.64 mM). The samples were incubated at 0uC for 40
minutes and then washed in 1 ml YPD. Then the cells were
resuspended in 200 ml YPD to start of endocytosis and incubated for
different time periods at 30uC. Samples were taken and washed in
16PBS before microscopic analysis.
Hyphal structures were stained according to procedures
formerly published. Lipid rafts were stained with filipin [16] using
a concentration of 16.6 mg/ml. F-actin was stained as described
[54] with the modification that instead of rhodamine-conjugated
phalloidin Alexafluor-488-conjugated phalloidin was used.
The structures were inspected with a Leica TCS SP5 confocal
microcroscope using the appropriate excitation and emission wave
lengths.
The steady-state level of intracellular rhodamine 6G was
determined using the protocol of Maesaki et al. [55]. The influx
and efflux of rhodamine 6G was measured as described [56].
Testing susceptibility to metabolic inhibitors and
zymolyase
To test strains for sensitivity to metabolic inhibitors, strains were
initially grown for 16 hours in YPD medium. Then the cell
suspensions were diluted in YPD to an OD600 of 0.05 and the cells
grown at 30uC for six hours. The cell number per ml was
determined with a hemacytometer and serially diluted in cold H2O.
Each five ml suspension containing about 20, 200, 2.000 or 20.000
cells were spotted onto YPD agar containing certain toxic
compounds. For each compound three concentrations were initially
tested for optimal results. After two or three days of growth at
30uC the agar plates were photographed. Growth susceptibility of
S. cerevisiae strains to 80 mM NaF in YPD was tested by inoculating in
medium with and without 50 mg/ml doxycycline and incubation for
46 hours at 30uC. The OD600 was measured at certain time points.
Sensitivity to zymolyaseTM (Seikagaku Biobusiness Corp., Japan)
was tested as follows. The strains (wild type, age3D and reintegrant)
were grown in YPD at 30uC to exponential phase (OD600 about 0.5).
After washing with water, the cells were resuspended in SCE+DTT
(1 M Sorbitol, 10 mM Na-Citrat (pH 7.5), 20 mM EDTA, 20 mM
DTT) for 30 minutes at 23uC. The cells were washed in SCE and an
amount of 2.56107 cells per ml SCE including zymolyase at a
concentration of 5, 10 or 20 mg/ml was incubated at 37uC for 30
minutes. One volume of 2% SDS was added and the OD600
measured. The percentage of viable cells was determined according
to the following equation: % viable cells = 1006 (OD600 with
zymolyase/OD600 of a control sample without zymolyase).
Results
Deletion of AGE3 from the C. albicans genome and gene
expression
To study the biological role of AGE3 in C. albicans we made
heterozygous and homozygous strains, UZ22 and UZ45 (Table 1),
respectively, that lack one or both alleles of AGE3. In addition, as a
control for phenotypic analyses an AGE3-reconstituted (‘‘reinte-
grant’’) strain, UZ55, was generated. In this strain, one copy of the
wild-type AGE3 gene had been reintegrated into the age3D strain at
the native genomic locus.
Both in YPD and SC medium age3D yeast cells formed
aggregates (Fig. 1A) which disintegrate when the coverslip and
the cells in suspension beneath are gently pressed to the slide. This
indicates that age3 mutant cells possibly adhere to each other or
have some defects in cell separation after division.
Gene expression analysis by Northern blotting (Fig. 1B) and qRT-
PCR analysis (Table 2) revealed that the gene is expressed
constitutively at similar high levels under yeast and hyphal growth
conditions. Under these conditions both the heterozygous and the
reintegrant strains showed a lower gene expression compared to the
wild type. This is probably the reason for the intermediate phenotype
(between wild-type and age3 mutant) shown by the heterozygote and
the reintegrant strains in most of the experiments described in this
study. The different AGE3 expression levels of the reintegrant strain
and the heterozygous strain could be caused possibly by expression of
the gene from the promoters of different alleles (was not investigated),
because the promoter regions of the two AGE3 alleles differ from each
other by several nucleotide insertions and deletions.
AGE3 is the functional ortholog of S. cerevisiae GCS1
The open reading frames (ORFs) of C. albicans AGE3 and
S. cerevisiae GCS1 encode for proteins of 379 and 352 amino acids
length, respectively. The protein sequences are 46.7% identical and
54.3% similar (E-value: 1.2e-89). The N-terminal ARF-GAP
domains show the highest homology (83.6% identity, 91.0%
similarity). To confirm that AGE3 is indeed the functional ortholog
of GCS1 we investigated whether AGE3 is able to complement some
known defects of the yeast gcs1D strain. To this end, the AGE3ORF
was cloned behind the doxycycline-dependent Tet promoter [44]
on the centromeric plasmid pCM252-U. The resulting plasmid
pCaAge3-2 was transformed into the homozygous diploid yeast
gcs1D strain ydl226c2/2 from the EUROSCARF collection [57].
The resulting strain was called UZ177. We then compared the
ability of UZ177, the gcs1D strain and the wild-type strain for
gentamycin susceptibility and sporulation efficiency, which depend
on Golgi and vacuole functions [58] and proper formation of the
prospore membrane [36]. Furthermore, the growth in the presence
of sodium fluoride which inhibits glycolysis by binding to enolase
[59] was compared. In each case the wild-type phenotype was
nearly fully restored in the mutant strain when the C. albicans AGE3
ORF was expressed (Fig. 2). This suggests that C. albicans AGE3 is
indeed the functional ortholog of S. cerevisiae GCS1 and probably
functions as an ARF-GAP. In parallel we found that doxycycline did
not have any influence on growth in liquid media on any S. cerevisiae
strain used in this study (not shown).
age3 mutant cells show a strong delay in endocytosis
To confirm that age3D cells have defects in intracellular vesicle
traffic, we studied their endocytotic efficiency after staining the
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cytoplasmic membrane with the lipophilic fluorescent dye FM4-64.
Although FM4-64 was internalized efficiently, many age3D cells
showed bright fluorescent spots in the cytoplasm or irregular
structures (even at later time points) which was observed less often in
cells of the wild-type and reintegrant strains (Fig. 3A and 3B).
Moreover, the age3 mutant cells had a clear delay of endocytosis
compared to wild-type cells. In contrast to mutant cells the vacuolar
membranes of many wild-type and reintegrant cells were stained
weakly even ten minutes after release of endocytosis (temperature
shift from 0 to 30uC after removing excess FM4-64) (Fig. 3A).
Compared to wild-type cells it took about 20 minutes longer (this
corresponds to about 1/3 of the doubling time) until 50% of the
mutant cells had taken up FM4-64 into the vacuolar membrane
(Fig. 3C). Although all mutant cells showed staining of the vacuolar
membrane after one hour, there were still several bright spots
observed in the cytoplasm and close to the cell membrane of many
mutant cells (Fig. 3B). This and the generally higher background
staining of cytoplasm indicates that mutant cells also endocytose
quantitatively less efficiently than wild-type cells.
The age3D strain has severe defects in hyphal and
invasive growth under several distinct conditions
We then studied filamentation of age3D cells under several
distinct growth conditions, both in liquid media, on agar surfaces
and when embedded in agar. Depending on the growth
conditions, the mutant strain showed more or less severe defects
in formation of long filaments in liquid media. True hyphae
formation of the age3D strain was most efficient in YPD containing
10% bovine serum and germ tube formation occurred as
efficiently as in wild-type background (albeit with a short delay
and a reduced germ tube length compared to wild-type cells).
However, during prolonged growth only 54.3% (standard
deviation (SD) = 4.6; about 400 cells of three cultures each were
determined) of the mutant cells further developed into filaments of
normal true hyphae appearance, whereas 91.3% (SD=1.4) of
wild-type cells and 75.6% (SD=3.9) of the heterozygous and 79.6
(SD=2.4) of the reintegrated cells showed normal appearance.
The rest of the mutant cells were single yeast cells, cells of aberrant
shape and also single cells with bent shape of the germ tube were
observed (Fig. 4A). Many filaments were shorter, sometimes of
undulating or helical shape and some appeared swollen at the end
of the apical cell. Filaments and cells grown in serum-containing
medium form huge aggregates. Fixation in ethanol and subsequent
separation of the filaments by digesting proteins with pepsin
resulted in osmotic shrinkage of filaments and made it very difficult
to distinguish filaments of different diameter and shape. Therefore
we were not able to determine the fractions of different aberant
cell and filament forms reliably. Filaments of ‘‘normal’’ appear-
Figure 1. Morphology of the age3D/D strain under yeast growth conditions and AGE3 gene expression. (A) The strains SN87 (AGE3+/+),
UZ22 (AGE3+/D), UZ45 (age3D/D) and UZ55 (age3D/D::AGE3) were grown in SD medium at 30uC to an OD600 of 0.5. Samples were inspected under the
microscope (phase contrast optics). Note that the homozygous age3 mutant strain forms aggregates of yeast cells. The heterozygous and the
reintegrant strain show intermediate phenotype. (B) Northern blotting of RNA isolated under yeast and hyphal growth conditions. The wild-type
strain, the heterozygous and the homozygous age3mutant strains were grown either to exponential phase in YPD or induced for hyphal growth (two
and six hours) in YPD +10% bovine serum. Each 4 mg total RNA were blotted and hybridized with a 32P-labeled AGE3-specific probe. Methylene blue-
stained rRNA on the blot is shown as a control for blotting efficiency.
doi:10.1371/journal.pone.0011993.g001
Table 2. AGE3 transcript levels in heterozygous and homozygous age3 mutant cells.
Strain AGE3 genotype Growth condition1 Relative AGE3 transcript level2
SN87 +/+ Yeast 1.00
Hyphae 2 hours 1.01
Hyphae 6 hours 0.93
UZ22 +/2 Yeast 0.45
Hyphae 2 hours 0.44
UZ45 2/2 Yeast 0.00
UZ55 2/2 (+) Yeast 0.69
Hyphae 2 hours 0.63
1The cells were grown either in YPD at 30uC to exponential phase (yeast) or induced for hyphal growth (hyphae) in YPD + bovine serum at 37uC for two or six hours.
2The transcript levels were determined by qRT-PCR and are given as mean levels of two parallel reactions compared to the AGE3 expression level of wild-type cells
grown under yeast growth conditions.
doi:10.1371/journal.pone.0011993.t002
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ance (without fixation) were composed of hyphal cells with a mean
length of about 73% of wild-type cells (Fig. 4B). The mean lengths
were 27.4 mm (63.44) for wild-type hyphal cells and 20.1 mm
(61.69) for mutant cells. However, the first hyphal cell of mutant
filaments was often as long as in wild-type filaments. A larger
difference of hyphae formation between age3D and wild-type cells
was observed in medium containing N-acetylglucosamine
(GlcNAc) (Fig. 4C), which strongly induces hyphal growth of
wild-type cells. Whereas around 80% of the wild-type cells
germinated and formed true hyphae of up to three cells three
hours after hyphal induction, only a fraction of about 8% of the
age3D cells germinated and the few filaments formed were
composed of no more than two cells. Many cells had an aberrant
shape. After five hours nearly 100% of the wild-type blastospores
germinated or the filaments had been elongated further, whereas
most of the mutant ‘‘filaments’’ were not able to elongate or divide
further (not shown). Also in Spider medium the age3D cells formed
very few short filaments (not shown). Most mutant cells were of
aberrant and often bent shape. The heterozygous and the
reintegrant strains showed an intermediate phenotype in all
media.
In conclusion, age3D cells are strongly compromised in
maintaining polarized filamentous growth after germ tube
formation in liquid media (the severity of these defects depending
on the medium).
We also investigated filamentous growth of the age3 mutant
when grown on Spider agar and when embedded in YPS agar
(Fig. 5). Compared with liquid media, the mutant strain showed an
even stronger filamentation defect on/in the agar media. Although
being able to form long filaments in the center of the colonies
grown on Spider agar, the colonies were easily washed from the
agar surface (Fig. 5A). Moreover, the age3D colonies were very flat
and larger compared to colonies formed by other strains. Under
embedded conditions the age3D strain formed very short filaments
instead of long and branched filaments observed with the wild-
type strain (Fig. 5B). From these results we conclude that AGE3 is
essential for invasive filamentous growth in C. albicans.
Filamentation deficiency of age3D cells correlates with
improper organization of the actin cytoskeleton and the
absence of lipid raft polarization at the hyphal tip
We next investigated whether age3D cells induced for hyphal growth
show polarization of the actin cytoskeleton and lipid rafts. As in other
forms of polarized growth of fungi the development of true hyphae
depends on the polarization of actin cables, which is established by
regulatory and structural cytoskeletal proteins and by cortical patches
Figure 2. CaAGE3 complements defects of the yeast gcs1D mutant. (A) The diploid S. cerevisiae strains BY4743 (wild type), ydl226c+/2
(heterozygous for GCS1), ydl226c2/2 (homozygous gcs1D) and UZ177 (homozygous gcs1D transformed with the centromeric plasmid pCaAge3-2
which carries the CaAGE3 ORF under control of the doxycycline-inducible Tet promoter) were grown for 48 hours on agar plates containing 50 mg/ml
doxycycline (DOX) in the presence of gentamycin (A). The number of cells spotted onto the agar was about 20,000, 2,000, 200 or 20 (from left to
right). (B) Exponentially pregrown cells (strains as in A) were inoculated into 80 mM sodium fluoride in YPD +50 mg/ml DOX and incubated at 30uC for
42 hours. Samples were taken after different time points and the OD600 measured. For control, each strain was also grown without DOX. Except for
strain UZ177 the growth rate was independent of the presence of DOX (not shown). However, AGE3 induction in strain UZ177 by DOX results in
complementation of the growth deficiency of gcs1D cells. This experiment was repeated and very similar growth behaviours were observed. (C) The
wild-type, the homozygous gcs1D strain and UZ177 were induced for sporulation on agar plates containing 1% potassium acetate and 50 mg/ml
DOX. The percentage of asci formation was determined after five days incubation at 30uC. This experiment was done in triplicate. Expression of
CaAGE3 complements the complete inability of the gcs1D/D strain to form asci. Note that in general the sporulation efficiency of strains derived from
BY4743 is low compared to other wild-type strains.
doi:10.1371/journal.pone.0011993.g002
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Figure 3. Cells lacking AGE3 show a clear delay in endocytosis. (A) Cells of the strains SN87 (AGE3+/+), UZ45 (age3D/D) and UZ55 (age3D/
D::AGE3) were grown in YPD to exponential phase. After staining the cytoplasmic membrane with the lipophilic fluorescent dye FM4-64 at 0uC for 40
minutes, the excess dye was removed by washing. Then the cells were released for growth in YPD at 30uC to allow endocytosis to occur. Samples
were taken at the indicated time points. Staining of endocytic vesicles and the vacuole was visualized by confocal fluorescence microscopy. DIC
images are shown for comparison. (B) One and two cell pairs of the wild-type and the age3D/D mutant strains, respectively, which were harvested 40
minutes after release of endocytosis are shown in higher magnification. The mutant cells show stronger background staining of the cytoplasm and
more bright spots compared to the wild-type cells. The vauolar membranes of the left mutant cells still have not taken up FM4-64. (C) Quantification
of FM4-64 uptake into vacuolar membranes in cells of the strains mentioned above. Images of a similar experiment as described under (A) were
analysed and the percentage of cells (about 100–150 in total for each strain and time point) with clearly stained vacuolar membranes determined. A
similar experiment performed on another day with slightly different time points showed a very similar FM4-64 uptake kinetics.
doi:10.1371/journal.pone.0011993.g003
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of actin [11–14,54]. Actin was stained with Alexafluor-488 phalloidin.
The high enrichment of lipid rafts at the hyphal tip [16] were stained
with the polyene filipin, which binds to ergosterol [60].
To study these structures, we induced mutant and wild-type
cells for hyphal growth in GlcNAc-containing medium, because
under these conditions we observed the mutant’s strongest defect
in hyphal growth. The wild-type strain showed the expected
concentration of actin patches at the tips of germ tubes and
hyphae (Fig. 6A). However, for most of the germ tubes (or germ
tube-like structures) and short filaments formed by age3D
blastospores, actin patches were scattered along the cell bodies
and a polarization pattern was rarely observed. A similar
Figure 4. Growth forms of the age3D/D strain after hyphal induction in YPD +10% bovine serum (A and B) or in GlcNAc medium (C).
(A) The strains SN87 (AGE3+/+), UZ22 (AGE3+/D), UZ45 (age3D/D) and UZ55 (age3D/D::AGE3) were induced for hyphal growth in YPD +10% bovine
serum at 37uC. After five hours of growth, samples were inspected under the microscope (most pictures in phase contrast and some in Nomarsky
optics). Note that the homozygous age3 mutant strain forms several distinct forms of filaments. Some of them are not true hyphal filaments. Most
strikingly, a fraction of germ tubes and filaments show an untypically curved or spiral shape (images e, g, h and i). Some other filaments show
constrictions between cells which are typical for pseudohyphae (i). There are also cell clusters seen which are composed of yeast-form cells (c) and
others which show only poor polarized growth (d, f and b arrow head). (B) Each one true hyphal filament of the wild-type and the age3mutant strains
grown under the same conditions as in (A) were stained with Calcofluor white and DAPI to visualize septa (arrow heads) and nuclei, respectively.
Compared to wild-type filaments, age3 mutant filaments are composed of shorter hyphal cells (except for the first cell following the blastospore in
many cases). (C) The strains SN87 (AGE3+/+), UZ45 (age3D/D) and UZ55 (age3D/D::AGE3) were induced for hyphal growth in GlcNAc-containing
medium. After three hours of growth at 37uC for each clone about 200 cells and filaments were classified as wild-type-like germ tubes and hyphae,
yeast cells and aberrant forms of single cells, germ tubes or filaments (curved shape, short pseudohyphal elements, cells with thick germ tubes; as
shown in (A)). The experiment was done in triplicate. The mean percentage of these morphologies and standard deviation are shown.
doi:10.1371/journal.pone.0011993.g004
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Figure 5. Defective filamentous and invasive growth of the age3D/D strain on/in solid media. Note: All images of each row are shown in
the same magnification. (A) The strains SN87 (AGE3+/+), UZ22 (AGE3+/D), UZ45 (age3D/D) and UZ55 (age3D/D::AGE3) were induced for filamentous
growth on Spider agar at 37uC for three and six days (two sets of agar plates). The colonies were photographed and the colony edges inspected
under the microscope. To try to remove the colonies after three days of growth one set of agar plates was washed with water. Only the homozygous
age3 mutant colonies could be removed easily. At the edges of the mutant colonies after wash single yeast cells and very short filaments are still
attached to the agar. However, weak invasive growth into the agar by age3 mutant filaments is only visible in the colony center. After six days,
filamentous growth is seen macroscopically for the wild-type, the heterozygous and the reintegrant strain. The mutant strain forms flat colonies
Candida albicans ARF-GAP Age3
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difference was observed for the distribution of lipid rafts (Fig. 6B).
Whereas wild-type hyphae showed the typical strong staining of
hyphal tips and septa with filipin, ergosterol and lipid rafts were
uniformly distributed in the cytoplasmic membrane of many age3
mutant filaments and germ tubes. As mentioned, age3D cells and
filaments show a certain variability in shape. Filaments which are
morphologically similar to the wild-type hyphae showed nearly
normal staining patterns of actin patches and lipid rafts (not
shown). The reintegrant strain was observed in parallel and
showed both wild-type and mutant staining patterns (not shown).
Cells lacking AGE3 are highly susceptible to several
unrelated toxic compounds
To identify other cellular functions of the Age3 protein in
C. albicans we determined the growth behaviour of the mutant
strain in the presence of several distinct metabolic inhibitors. As
shown in Fig. 7, the age3D strain showed high susceptibility to
hygromycin B, the azole drugs miconazole and itraconazole,
SDS, Cd2+ ions and brefeldin A. In the presence of 5-
fluorocytosine and amphotericin B, which are both used in
antifungal therapy in combination with or without azoles [19],
we did not observe any influence on growth in the absence of
AGE3. The sensitivity of mutant cells to brefeldin A, which is an
inhibitor of ARF-GEFs (ARF guanine nucleotide exchange
factors; these are required for restoring the potentially active
ARF-GTP complex) [61], confirms a role of the Age3 protein in
the process of vesicle uncoating. The toxic compounds identified
have different chemical structures and are involved in inhibition
of distinct cellular processes and structures, such as protein
glycosylation, cell wall and protein synthesis (hygromycin B),
ergosterol biosynthesis and lipid composition of the plasma
membrane (azoles), as well as other membrane or cell wall
defects (SDS), and heavy metal toxicity (cadmium ions). Since
yeast Gcs1p, and probably C. albicans Age3p as well, function as
ARF-GAPs and are required for efficient vesicle traffic, the
pleiotropic susceptibility spectrum may be caused mainly by
improper or defective intracellular vesicle and protein transport
to different organelles and membranes of most age3D cells. In
particular, the high sensitivity of age3D cells to azoles,
hygromycin B and cadmium may be caused by inefficient
transport of drug efflux pumps to the plasma membrane. As a
consequence age3 mutant cells could have a much lower
capacity to remove these compounds from the cell.
The drug efflux pumps Cdr1p, Cdr2p and Mdr1p are
properly localized in age3D cells
From the hypothesis described above, we expected that, as a
consequence of inefficient transport of drug efflux pumps to the
membrane, a high amount of these transporters may be present in the
cytoplasm instead of the plasma membrane in age3D cells. To test this
hypothesis, we constructed C. albicans strains expressing chimeric
proteins composed of drug efflux pumps C-terminally fused with
GFP. The efflux pumps chosen were Cdr1p [62] andMdr1p [63,64],
two well studied drug transporters belonging to two distinct classes of
efflux pumps. Both proteins are able to efflux azoles [62,65].
However, both the GFP fusion protein of Cdr1p and that ofMdr1p
are predominantly localized in the plasma membrane in both the
age3D and AGE3wild-type background (Fig. 8A). That translocation of
drug transporters to the plasma membrane does not significantly
depend on Age3p function was further confirmed byWestern blotting
of plasma membrane proteins isolated from yeast-form cells of the
wild-type, the age3D, and reintegrant strains and immunostaining with
Figure 6. Absence of polarization of lipid rafts and actin patches in age3D cells. The strains SN87 (AGE3+/+) and UZ45 (age3D/D) were
induced for hyphal growth in GlcNAc medium at 37uC. After three hours samples were taken and the cell structures shown were stained and
visualized under the confocal microscope. For control, pictures made with phase contrast or DIC optics are shown below the fluorescence picture. (A)
At the tips of germ tubes of wild-type cells the actin patches, which were stained with Alexafluor 488-conjugated phalloidin, are highly concentrated.
Most mutant cells do not show this polarization of the actin cytoskeleton. (B) Lipid rafts were stained with filipin. As expected, lipid rafts are
concentrated at the hyphal tips and at septa in the wild type. Most mutant germ tubes (note that some have constrictions at the neck) and filaments
show a uniform staining of the cytoplasmic membrane. Note that the figure shows only typical structures found in cultures of wild-type and mutant
cells. However, a low fraction of mutant cells and filaments (see Fig. 4C) showed a wild type-like staining patterns. Also for the reintegrant strain (not
shown) both wild-type and mutant staining patterns were observed.
doi:10.1371/journal.pone.0011993.g006
without visible filaments (as also seen after three days). (B) The strains mentioned under (A) were induced for filamentous growth by embedding in
YPS agar and incubation for three days at 37uC. The homozygous age3 mutant colonies formed after two days of growth show a high rate of
filamentation. However, the filaments were unable to develop further (three days) into long filaments which could invade the agar as filaments of the
control strains do.
doi:10.1371/journal.pone.0011993.g005
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antibodies raised against Cdr1p, Cdr2p (which is also able to efflux
azoles) and Mdr1p (kindly provided by D. Sanglard) [52]. The results
revealed that the plasma membrane of mutant cells contained similar
amounts of Cdr1p and Cdr2p and possibly a somewhat lower Mdr1p
amount compared to the membranes isolated from wild-type and
reintegrant cells (Fig. 8B). Moreover, the intracellular steady-state level
of rhodamine 6G (R6G), a substrate of Cdr1p and Cdr2p, but not of
Mdr1p [55], is only slightly increased (,8%) in age3D cells compared
to wild-type cells after growth for one hour at 22, 30 or 37uC (Fig. 8C).
Furthermore, de-energized (depleted for ATP) exponentially growing
age3 mutant cells showed only a slight increase of R6G influx
compared to wild-type cells (data not shown). The R6G efflux rate
after glucose-addition (activation of the ATP-dependent efflux pumps)
was similar (not shown). These results indicate that the higher drug
susceptibility of age3D cells is not the result of poor transport to the cell
membrane and lower activity of the Cdr1 and Cdr2 proteins.
The age3D cells are less susceptible to the cell wall-lytic
enzyme zymolyase
Since hygromycin B is not a substrate of Cdr1p and Mdr1p
[66] and susceptibility of age3D cells to hygromycin B and SDS
points to defects in the cell wall, we investigated the sensitivity
of age3D cells to the cell-wall lytic enzyme zymolyase.
Unexpectedly, instead of being more sensitive, the mutant
cells were more resistant to zymolyase compared to wild-type
cells. This was tested by using two different approaches, cell
viability determination (not shown) and measuring the
decrease of optical density after spheroplast formation by
zymolyase treatment and subsequent cell lysis with SDS (Fig. 9).
Discussion
In this paper we describe the phenotypic and physiological
consequences of deleting the AGE3 gene from the C. albicans genome.
Since it is able to complement defects of S. cerevisiae gcs1D cells, AGE3
is probably the functional ortholog of the S. cerevisiae GCS1 gene. The
age3D strain showed a clear delay in endocytosis, which is consistent
with an important function of Age3p in endosomal compartments as
it has been also shown for its yeast ortholog [29,33].
Hyphal and invasive growth defects of the age3D mutant
strain
As we have shown the poor ability of the cells to form true hyphae
and the formation of aberrant cell and filament shapes under a number
of hyphal growth conditions is possibly caused by the defects in actin
polarization. Moreover, the morphology of age3D cells induced for
hyphal growth closely resembles that of other mutants with defective
polarization of the actin cytoskeleton [12,14]. This suggests that, similar
to Gcs1p [37], Age3p can stimulate actin polymerization.
Proper formation of the actin cytoskeleton and cortical actin
patch localization depends on both exo- and endocytosis [19].
Moreover, cell polarization depends on the localization of the
Cdc42 GTPase, the master regulator of polarized growth, to the
polar cap. Its essential role in hyphal growth of C. albicans is well
studied [67–69]. It has been shown in yeast that Cdc42p shuttles in
a dynamic flux between the cytoplasmic membrane at the polar
cap and the cytoplasm [70]. Apart from GDP/GTP recycling on
Cdc42p, robust maintenance of cell polarity depends on an actin-
dependent efficient exocytic transport of internalized Cdc42p-
containing vesicles and subsequent fusion with the cytoplasmic
membrane [70]. As discussed above, age3D cells have a defect in
the endocytic pathway. Thus the defect of age3D cells to maintain
the balance of polarized versus isotropic growth, which is required
to sustain true hyphal growth after germ tube formation, is
probably a combination of disturbed polarization of the actin
cytoskeleton and inefficient vesicle trafficking.
As observed for a C. albicans strain that lacks the gene encoding for
the polarisome component Spa2p [14], the defect of the age3D strain in
Figure 7. The age3D mutant strain is susceptible to several unrelated metabolic inhibitors. The strains SN87 (AGE3+/+), UZ22 (AGE3+/D),
UZ45 (age3D/D) and UZ55 (age3D/D::AGE3) were grown in YPD medium at 30uC to an OD600 of 0.5. After washing, the cells were spotted in serial
dilutions (cell number per spot is given) onto agar plates containing distinct concentrations of the toxic compounds mentioned and grown for two or
three days at 30uC. The homozygous age3 mutant cells are susceptible to the azole drugs miconazole and itraconazole, hygromycin B (HygB),
cadmium ions, SDS and brefeldin A, but not to the antifungal drugs amphotericin B (AmB) and 5-fluorocytosine (5-FC). Note, that as observed for
other phenotypes, the heterozygous and the reintegrant strain show an intermediate susceptibility between the wild-type and the homozygous
mutant strains. In the experiments shown in the upper panel two independent clones (1 and 2) of the construction of the homozygous age3D strain
were spotted. Since these clones behaved identical, only clone 1 was used in later experiments (lower panel).
doi:10.1371/journal.pone.0011993.g007
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hyphal growth was more pronounced on solid than in liquid media.
Furthermore, we have shown that AGE3 is essential for invasive
filamentous growth in vitro. It is commonly acknowledged that, apart
from filamentous growth per se, the ability of C. albicans to invade host
tissues strongly contributes to virulence of this and other pathogenic
fungi [4,69,71]. Consistent with this, Epp et al. [38] found that the
age3D strain is much less virulent compared to the wild-type strain.
AGE3 is required for tolerance of several unrelated toxic
compounds including azole drugs
The high susceptibility of age3mutant cells to several structurally
unrelated toxic compounds, which affect distinct functions of the
cell, could be caused simply by the pleiotropic consequences of
disturbed vesicle traffic of several routes to different compartments
of age3D cells. Since the drug transporters Cdr1p, Cdr2p and
Mdr1p were efficiently transported to the cell membrane in age3D
cells and the steady-state level of rhodamine 6G was in a similar
range as in wild-type cells, the high azole sensitivity of mutant cells
is probably not the consequence of poor drug efflux activity. In
addition, age3D cells did not show a higher susceptibility to
amphotericin B which directly binds to ergosterol [19]. This
strongly suggests that age3D cells have no defect in ergosterol
biosynthesis, a process that is targeted by azoles. Taken together,
other cellular functions that are involved in tolerance to azoles and
Figure 8. Plasma membrane localization of Cdr1p, Cdr2p and
Mdr1p and intracellular rhodamine 6G steady-state level in
age3 mutant cells. (A) Wild-type and age3D strains which encode
either a Cdr1p-GFP fusion protein (TL19 and TL20) or a Mdr1p-GFP
fusion protein (TL21 and TL22), respectively, were grown to exponential
phase in the presence of doxycycline or benomyl (gene-ON conditions)
at 30uC. Cdr1p-GFP and Mdr1p-GFP were visualized by confocal
fluorescence microscopy and were predominantly localized in the
cytoplasmic membrane independent of the AGE3 genotype. The diffuse
intracellular cloud of GFP fluorescence visible in most cells of all strains
colocalizes with the vacuole (DIC images are not shown). (B) The
proteins (10 mg per sample) of the membrane fractions, which were
isolated from SN87 (AGE3+/+), UZ45 (age32/2) and UZ55 (age32/
2::AGE3) cells each induced either with b-estradiol for CDR1 and CDR2
expression or with benomyl for MDR1 expression, were separated by
SDS-PAGE (10%) and blotted onto nitrocellulose membranes. Cdr1,
Cdr2 and Mdr1 proteins were detected after immunostaining with
polyclonal antibodies (color development with BCIP and NBT). (C) The
same strains as in (B) were grown to exponential phase in YPD medium.
After washing, the cells were incubated for one hour in 10 mM
rhodamine 6G (R6G) in CYG medium at the indicated temperatures. The
experiment was done in triplicate and the mean percentage of
intracellular R6G level and the standard deviation are shown. At each
temperature the intracellular R6G amount in age3 mutant cells was only
slightly higher (,8%) than in wild-type cells.
doi:10.1371/journal.pone.0011993.g008
Figure 9. Increased resistance of age3D cells to zymolyase. The
strains SN87 (AGE3+/+), UZ45 (age3D/D) and UZ55 (age3D/D::AGE3)
were grown at 30uC to an OD600 of 0.5. An amount of 10
7 cells per ml
was incubated at 37uC for 30 minutes with zymolyase at a
concentration of 5, 10 or 20 mg/ml. After addition of an equal volume
of 2% SDS the OD600 was measured and the percentage of viable cells
determined (cells without zymolyase treatment were used as control).
The experiment was done in triplicate. The mean percentage and
standard deviation are shown. The age3 mutant cells show a higher
resistance to zymolyase compared to wild-type and reintegrant cells.
doi:10.1371/journal.pone.0011993.g009
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possibly also to the other compounds affecting growth of age3D
cells must be compromised in age3D cells.
Few studies revealed an important role of the vacuole in azole
detoxification. C. albicans mutant cells lacking the genes of the
vacuolar protein sorting factors Vps1p, Vps28p or Vps32p (Snf7p)
are more susceptible to fluconazole compared to wild-type cells
[72,73]. Epp et al. [38] found that fluconazole exerts a very strong
fungistatic activity on C. albicans mutant cells lacking the Vma10
subunit of the vacuolar membrane H+-ATPase, which they also
found for S. cerevisiae mutants lacking other V-ATPase subunits.
Moreover, several fluconazole-resistant strains isolated from
patients after fluconazole administration for several weeks highly
accumulate the drug (or some modified form or degradation
product) in vesicular vacuoles [74]. Altogether these studies
strongly indicate that the vacuole has some important, but yet
undefined function in detoxification of azoles.
Interestingly, the vps1, vps28, vps32 deletion strains [72,73] and
the fluconazole-resistant strains described by Maebashi et al. [74]
do not show an increased susceptibility to amphotericin B and 5-
fluorocytosine compared to the wild type. This susceptibility
pattern agrees with the one we found for age3D cells. Moreover, we
found a higher susceptibility of age3D cells to hygromycin B, SDS
and cadmium ions. In C. albicans or S. cerevisiae an involvement of
the vacuole in susceptibility and/or detoxification of hygromycin B
[75], SDS [73] and cadmium [76] has been found. From this
compound susceptibility pattern and the endocytic defect of age3D
cells we conclude that the drug susceptibility of age3D cells may be
caused by some yet undefined defect in vacuolar function. A study
to confirm this hypothesis is under way. Whether the glutathione
S-conjugate pump Ycf1p [76] or another glutathione-dependent
(or -independent) ABC transporter in the vacuolar membrane, like
Mlt1p [77], is able to sequester azoles into the vacuolar lumen is
unknown yet. Interestingly, it has been shown that glutathione S-
transferases, which catalyse the conjugation of glutathione to
xenobiotics and other substrates, are involved in fluconazole
detoxification in Schizosaccharomyces pombe [78].
An involvement in vesicle and protein traffic from the Golgi
apparatus to the vacuole via the endosomal route has been shown
for yeast Gcs1p [31,32,36,79]. The strong delay of C. albicans age3D
cells in the endocytic route to the vacuole could result in a much
lower amount of drug transporters in the vacuolar membrane and
toxic compound-degrading enzymes in the vacuolar lumen. This
would have a strong impact on susceptibility of the cell to toxic
compounds.
The high sensitivity to the cell-wall perturbing compounds
hygromycin B and SDS and the reduced sensitivity to cell wall
degradation by ZymolyaseTM (which includes several enzymes that
are able to hydrolyse the major components of the fungal cell wall)
compared to the wild type indicate that the cell wall composition
of age3D and wild-type cells differ.
In summary, we conclude that the mutant phenotypes of
age3D cells result from a defect in proper polarization of the
actin cytoskeleton, inefficient endocytosis, and possibly ineffi-
cient vacuolar functions. The phenotypic consequences of the
absence of Age3p described here probably have strong impacts
on virulence of C. albicans and antifungal therapy which both
are affected by deletion of AGE3 [38]. Therefore, the protein is
an ideal candidate target for the development of new antifungal
compounds.
Supporting Information
Figure S1 Southern blots confirming the AGE3 genomic regions
of the homozygous age3 mutant (A) and AGE3-reconstituted
strains (B). Genomic DNA isolated from the strains indicated was
digested with restriction enzymes and the fragments separated by
agarose gel electrophoresis. After blotting onto a nylon membrane
and hybridization with a [32P]-labelled probe, AGE3 promoter-
specific fragments were visualized by phosphoimaging. DNA was
digested either with SnaBI and KpnI (A) or with EcoRV and XbaI
(B). For both the homozygous age3 mutant and the AGE3-
reconstituted strains the expected fragment patterns were
observed. (*) For the reconstituted strain two AGE3 promoter-
specific fragments (ca. 1620 and 5000 bp) were expected.
Found at: doi:10.1371/journal.pone.0011993.s001 (0.78 MB
TIF)
Figure S2 Multistep construction of the pTet-GFP plasmid.
Restriction sites shown in parentheses are not singular on the
corresponding plasmid, all other sites shown are singular. * At this
XbaI site, only DNA isolated from E. coli dam- strains can be cut.
The final construct is composed of the gene cassettes and
fragments shown in the table at the right side cloned on a
pBluescript KS(+) backbone. The generation of the inserted PCR
products of each cloning step is shown in the table. pTet-GFP can
be used for construction of C-terminal gene fusions with GFP. The
gene of interest should be inserted between the singular EcoRI (or
alternatively, XhoI, SalI, PstI or SmaI) and NgoMIV (NaeI) sites.
The translational start codon of the gene has to be included
immediately following the EcoRI site. Upstream of the NgoMIV
site three spacer tandem repeats of Gly-Ala codons (which separate
the fused genes) should be inserted at the end of the gene without a
stop codon. The resulting recombinant plsamid can be linearized
in the RPS1’ gene fragment using the singular restriction sites AgeI
or BglII (not shown) and integrated into the RPS1 gene. After
transformation, recombinant C. albicans clones can be selected for
hygromycin B resistance. The chimaeric gene is under control of
the Tet promoter and can be induced by addition of doxycycline
to the growth medium. Alternatively, if the plasmid is to be
integrated into the native gene locus (ORF), the expression of the
GFP fusion construct will be controlled by the native gene
promoter.
Found at: doi:10.1371/journal.pone.0011993.s002 (1.30 MB
TIF)
Table S1 Oligonucleotides used in this study.
Found at: doi:10.1371/journal.pone.0011993.s003 (0.06 MB
DOC)
Table S2 Plasmids used in this study.
Found at: doi:10.1371/journal.pone.0011993.s004 (0.04 MB
DOC)
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